Composition for preventing or treating atopic dermatitis
US11878008B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2020 |
| Grant date | Jan 23, 2024 |
| Priority date | — |
| Expiry date | Aug 9, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for preventing or treating atopic dermatitis using TRPV1 receptor antagonist. More specifically, it may be possible to prevent and/or treat the atopic dermatitis without any side effects such as an increase in body temperature, epidermal atrophy, and the like by percutaneously administrating a composition for external use on the skin containing the TRPV1 receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.